AU2001264166A1 - Vector constructs - Google Patents

Vector constructs

Info

Publication number
AU2001264166A1
AU2001264166A1 AU2001264166A AU6416601A AU2001264166A1 AU 2001264166 A1 AU2001264166 A1 AU 2001264166A1 AU 2001264166 A AU2001264166 A AU 2001264166A AU 6416601 A AU6416601 A AU 6416601A AU 2001264166 A1 AU2001264166 A1 AU 2001264166A1
Authority
AU
Australia
Prior art keywords
vector constructs
constructs
expression
double
stranded rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264166A
Other languages
English (en)
Inventor
Thierry Bogaert
Geert Plaetinck
Jean-Pierre Renard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9891999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001264166(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Devgen NV filed Critical Devgen NV
Publication of AU2001264166A1 publication Critical patent/AU2001264166A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Optical Communication System (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
  • Control Of Ac Motors In General (AREA)
  • Soft Magnetic Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2001264166A 2000-05-19 2001-05-18 Vector constructs Abandoned AU2001264166A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0012233.3A GB0012233D0 (en) 2000-05-19 2000-05-19 Vector constructs
GB0012233 2000-05-19
PCT/IB2001/001068 WO2001088121A1 (en) 2000-05-19 2001-05-18 Vector constructs

Publications (1)

Publication Number Publication Date
AU2001264166A1 true AU2001264166A1 (en) 2001-11-26

Family

ID=9891999

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264166A Abandoned AU2001264166A1 (en) 2000-05-19 2001-05-18 Vector constructs

Country Status (9)

Country Link
US (2) US7358069B2 (enExample)
EP (2) EP1285062B1 (enExample)
JP (2) JP5153983B2 (enExample)
AT (2) ATE354652T1 (enExample)
AU (1) AU2001264166A1 (enExample)
DE (2) DE60143718D1 (enExample)
ES (2) ES2356389T3 (enExample)
GB (2) GB0012233D0 (enExample)
WO (1) WO2001088121A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs
US7612194B2 (en) * 2001-07-24 2009-11-03 Monsanto Technology Llc Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
US20040180438A1 (en) 2002-04-26 2004-09-16 Pachuk Catherine J. Methods and compositions for silencing genes without inducing toxicity
WO2003095652A2 (de) * 2002-05-08 2003-11-20 Xantos Biomedicine Ag EXPRESSIONSKONSTRUKTE ZUR HERSTELLUNG VON DOPPELSTRANG (ds) RNA UND DEREN ANWENDUNG
AU2003239897A1 (en) 2002-05-23 2003-12-12 Ceptyr, Inc. Modulation of ptp1b signal transduction by rna interference
EP2316922B1 (en) * 2002-05-24 2013-05-22 Merck Sharp & Dohme Corp. Neutralizing human anti-IGFR antibody
WO2004001044A1 (en) * 2002-06-21 2003-12-31 Sinogenomax Company Ltd. Randomised dna libraries and double-stranded rna libraries, use and method of production thereof
US20050196862A1 (en) * 2002-08-30 2005-09-08 Wooddell Christine I. DNA cassette for cellular expression of small RNA
US7326567B2 (en) 2003-11-12 2008-02-05 Schering Corporation Plasmid system for multigene expression
AR046639A1 (es) 2003-11-21 2005-12-14 Schering Corp Combinaciones terapeuticas de anticuerpo anti- igfr1
US20060021087A1 (en) 2004-04-09 2006-01-26 Baum James A Compositions and methods for control of insect infestations in plants
PL1799028T3 (pl) * 2004-09-24 2015-06-30 Simplot Co J R Wyciszanie genów
EP1807522B1 (en) 2004-10-21 2013-11-20 Venganza Inc. Methods and materials for conferring resistance to pests and pathogens of plants
EP1807520B1 (en) 2004-10-25 2012-07-25 Devgen NV Rna constructs
US20060242736A1 (en) 2004-12-23 2006-10-26 Shihshieh Huang Dissimilar promoters for gene suppression
CA2610644A1 (en) 2005-05-31 2006-12-07 Devgen Nv Rnai for control of insects and arachnids
EP2269444A3 (en) 2005-09-16 2012-04-04 deVGen N.V. DSRNA as insect control agent
EP2295584B1 (en) 2005-09-16 2015-06-10 deVGen N.V. Transgenic plant-based methods for plant pests using RNAi
BRPI0616181B1 (pt) 2005-09-16 2024-03-05 Monsanto Technology Llc Construção de polinucleotídeo isolada, sequência de ribonucleotídeo de fita dupla, microrganismo transgênico, seu método de produção, e métodos para controle de infestação por coleóptero praga, para melhorar o rendimento e a tolerância a estiagem de um cultivo, e para produção de um produto comercial, alimento ou ração
US8906876B2 (en) 2006-01-12 2014-12-09 Devgen Nv Methods for controlling pests using RNAi
US20090285784A1 (en) 2006-01-12 2009-11-19 Devgen Nv DSRNA As Insect Control Agent
WO2007080126A2 (en) 2006-01-12 2007-07-19 Devgen N.V. Dsrna as insect control agent
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
US9944948B2 (en) 2010-10-27 2018-04-17 Devgen Nv Down-regulating gene expression in insect pests
WO2013071047A1 (en) * 2011-11-11 2013-05-16 Children's Medical Center Corporation Compositions and methods for in vitro transcription of rna
EP3938518A4 (en) 2019-03-12 2023-01-11 Terra Bioworks, Inc. EXPRESSION VECTOR
WO2022011082A1 (en) * 2020-07-08 2022-01-13 Stellate Biotherapeutics, Inc. Compositions and methods for producing single stranded dna

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
US5017488A (en) 1986-04-01 1991-05-21 University Of Medicine And Dentistry Of New Jersey Highly efficient dual T7/T3 promoter vector PJKF16 and dual SP6/T3 promoter vector PJFK15
US5955363A (en) 1990-01-03 1999-09-21 Promega Corporation Vector for in vitro mutagenesis and use thereof
DE69119083T2 (de) 1990-09-27 1996-10-17 Invitrogen Corp Direkte klonierung von pcr amplifizierten nukleinsäuren
WO1993016170A1 (en) * 1992-02-06 1993-08-19 Gil Ho Choi Genetically engineered transmissible hypovirulence
DE69433201T2 (de) * 1994-02-28 2004-07-29 Shimadzu Corp. Oligonukleotide und Verfahren zum Nachweis von Bakterien
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
JPH11507532A (ja) * 1995-06-07 1999-07-06 ワシントン ユニバーシティ 環境に制限される生存能を有する組換え細菌システム
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
FR2782325B1 (fr) * 1998-08-12 2002-05-24 Proteus Procede d'identification de sequences polynucleotidiques et/ou des proteines correspondantes a partir d'un echantillon d'acides nucleiques
GB9827152D0 (en) * 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
US6326193B1 (en) * 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs

Also Published As

Publication number Publication date
DE60126760T2 (de) 2007-11-15
ATE492638T1 (de) 2011-01-15
DE60143718D1 (de) 2011-02-03
EP1775345A2 (en) 2007-04-18
US7358069B2 (en) 2008-04-15
EP1285062A1 (en) 2003-02-26
DE60126760D1 (de) 2007-04-05
EP1285062B1 (en) 2007-02-21
EP1775345A3 (en) 2007-09-05
ES2281420T3 (es) 2007-10-01
GB0112213D0 (en) 2001-07-11
ES2356389T3 (es) 2011-04-07
WO2001088121A1 (en) 2001-11-22
US7932062B2 (en) 2011-04-26
US20080241894A1 (en) 2008-10-02
ATE354652T1 (de) 2007-03-15
EP1775345B1 (en) 2010-12-22
JP5153983B2 (ja) 2013-02-27
GB2365867A (en) 2002-02-27
JP2012228256A (ja) 2012-11-22
JP5645886B2 (ja) 2014-12-24
GB2365867B (en) 2002-08-14
JP2004524804A (ja) 2004-08-19
GB0012233D0 (en) 2000-07-12
US20040166580A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
AU2001264166A1 (en) Vector constructs
AU2002332679A1 (en) Targeted nucleic acid constructs and uses related thereto
AU144678S (en) Bottle
AU2001294890A1 (en) Pei: dna vector formulations for in vitro and in vivo gene delivery
AU2002230591A1 (en) Genes associated with mechanical stress, expression products therefrom, and uses thereof
WO2001088103A3 (en) Compositions and methods for tissue dedifferentiation and regeneration
AU2002367580A1 (en) Tissue-engineered organs
AU2001288249A1 (en) Biosensors and methods for their use
AU2001285047A1 (en) Human genes and gene expression products
AU2001245619A1 (en) Human genes and gene expression products
AU2002331313A1 (en) Use of l-polynucleotides and derivatives thereof for in vivo imaging
EP1219636A3 (en) Modified muteins of erythropoietin (EPO) derived from in vitro or in vivo expression system of microorganisms
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
AU2002365077A1 (en) Methods and products related to non-viral transfection
AU1074902A (en) Kahalalide f
AU2002223470A1 (en) Modulation of the transcription of pro-inflammatory gene products
PL370703A1 (en) Cell constructs cultured in vitro, preparation and uses
AU2002220697A1 (en) Isolated luciferases lu164, lual and lu22, and the use of the same
AU2001270478A1 (en) Gene expression in biological conditions
AU2002215765A1 (en) Light-activated in vitro assay process for luciferase bioluminescence
AU6424501A (en) Novel enzyme gene and its expression product
AU2001264245A1 (en) Novel enzyme gene and its expression product
WO2002036167A8 (en) Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids
WO2002062943A3 (fr) Utilisation d'oligonucléotides pour améliorer la transfection des plasmides dans les cellules, procédé et kit de transfection.
EP1263986A4 (en) Platform for the identification of bacterial genes which are used in the modification of RNA